TY - JOUR
T1 - Post-Bariatric Hypoglycemia
T2 - an Impaired Metabolic Response to a Meal
AU - Aydin, Ömrüm
AU - Meijnikman, Abraham S.
AU - de Jonge, Patrick A.
AU - van Stralen, Karlijn
AU - Börger, Hanneke
AU - Okur, Kadriye
AU - Iqbal, Zainab
AU - Warmbrunn, Moritz V.
AU - Acherman, Yair I. Z.
AU - Bruin, Sjoerd
AU - Winkelmeijer, Maaike
AU - Schimmel, Alinda W. M.
AU - Holst, Jens J.
AU - Poulsen, Steen S.
AU - Bäckhed, Fredrik
AU - Nieuwdorp, Max
AU - Groen, Albert K.
AU - Gerdes, Victor E. A.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Aims/Hypothesis: Post-bariatric hypoglycemia (PBH) is caused by postprandial hyperinsulinemia, due to anatomical alterations and changes in post-prandial metabolism after bariatric surgery. The mechanisms underlying the failing regulatory and compensatory systems are unclear. In this study, we investigated the differences in post-prandial hormones and metabolic profiles between patients with and without PBH. Methods: We performed a mixed meal test (MMT) in 63 subjects before and 1 year after Roux-en-Y gastric bypass (RYGB) surgery. Blood was withdrawn at 0, 10, 20, 30, 60, and 120 min after ingestion of a standardized meal. Glucose, insulin, GLP-1, FGF-19, and FGF-21 were measured and untargeted metabolomics analysis was performed on blood plasma to analyze which hormonal and metabolic systems were altered between patients with and without PBH. Results: Out of 63, a total of 21 subjects (33%) subjects developed PBH (glucose < 3.1 mmol/L) after surgery. Decreased glucose and increased insulin excursions during MMT were seen in PBH (p < 0.05). GLP-1, FGF-19, and FGF-21 were elevated after surgery (p < 0.001), but did not differ between PBH and non-PBH groups. We identified 20 metabolites possibly involved in carbohydrate metabolism which differed between the two groups, including increased carnitine and acylcholines in PBH. Conclusion: Overall, 33% of the subjects developed PBH 1 year after RYGB surgery. While GLP-1, FGF-19, and FGF-21 were similar in PBH and non-PBH patients, metabolomics analysis revealed changes in carnitine and acyclcholines that are possibly involved in energy metabolism, which may play a role in the occurrence of PBH. Graphical Abstract: (Figure presented.)
AB - Aims/Hypothesis: Post-bariatric hypoglycemia (PBH) is caused by postprandial hyperinsulinemia, due to anatomical alterations and changes in post-prandial metabolism after bariatric surgery. The mechanisms underlying the failing regulatory and compensatory systems are unclear. In this study, we investigated the differences in post-prandial hormones and metabolic profiles between patients with and without PBH. Methods: We performed a mixed meal test (MMT) in 63 subjects before and 1 year after Roux-en-Y gastric bypass (RYGB) surgery. Blood was withdrawn at 0, 10, 20, 30, 60, and 120 min after ingestion of a standardized meal. Glucose, insulin, GLP-1, FGF-19, and FGF-21 were measured and untargeted metabolomics analysis was performed on blood plasma to analyze which hormonal and metabolic systems were altered between patients with and without PBH. Results: Out of 63, a total of 21 subjects (33%) subjects developed PBH (glucose < 3.1 mmol/L) after surgery. Decreased glucose and increased insulin excursions during MMT were seen in PBH (p < 0.05). GLP-1, FGF-19, and FGF-21 were elevated after surgery (p < 0.001), but did not differ between PBH and non-PBH groups. We identified 20 metabolites possibly involved in carbohydrate metabolism which differed between the two groups, including increased carnitine and acylcholines in PBH. Conclusion: Overall, 33% of the subjects developed PBH 1 year after RYGB surgery. While GLP-1, FGF-19, and FGF-21 were similar in PBH and non-PBH patients, metabolomics analysis revealed changes in carnitine and acyclcholines that are possibly involved in energy metabolism, which may play a role in the occurrence of PBH. Graphical Abstract: (Figure presented.)
KW - Bariatric surgery
KW - FGF-19
KW - FGF-21
KW - GLP-1
KW - Gluconeogenesis
KW - Hypoglycemia
UR - https://www.scopus.com/pages/publications/85201390365
U2 - 10.1007/s11695-024-07309-y
DO - 10.1007/s11695-024-07309-y
M3 - Article
C2 - 39153140
SN - 0960-8923
VL - 34
SP - 3796
EP - 3806
JO - Obesity surgery
JF - Obesity surgery
IS - 10
ER -